-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Inhibrx, Inc. quarterly/annual Revenues history and growth rate from Q3 2019 to Q1 2024.
- Inhibrx, Inc. Revenues for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
- Inhibrx, Inc. Revenues for the twelve months ending March 31, 2024 was $1.78M, a 39.3% increase year-over-year.
- Inhibrx, Inc. annual Revenues for 2023 was $1.8M, a 17.9% decline from 2022.
- Inhibrx, Inc. annual Revenues for 2022 was $2.19M, a 69.7% decline from 2021.
- Inhibrx, Inc. annual Revenues for 2021 was $7.23M, a 43.9% decline from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)